241 related articles for article (PubMed ID: 19457998)
1. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.
Johnson JB; Grant K; Parks GD
J Virol; 2009 Aug; 83(15):7602-11. PubMed ID: 19457998
[TBL] [Abstract][Full Text] [Related]
2. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.
Johnson JB; Capraro GA; Parks GD
Virology; 2008 Jun; 376(1):112-23. PubMed ID: 18440578
[TBL] [Abstract][Full Text] [Related]
3. Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization.
Johnson JB; Lyles DS; Alexander-Miller MA; Parks GD
J Virol; 2012 Sep; 86(18):9929-40. PubMed ID: 22761385
[TBL] [Abstract][Full Text] [Related]
4. Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.
Li Y; Johnson JB; Parks GD
Virology; 2016 Oct; 497():305-313. PubMed ID: 27505156
[TBL] [Abstract][Full Text] [Related]
5. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
[TBL] [Abstract][Full Text] [Related]
6. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
Li Y; Parks GD
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
[TBL] [Abstract][Full Text] [Related]
7. Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation.
Devaux P; Christiansen D; Fontaine M; Gerlier D
Eur J Immunol; 1999 Mar; 29(3):815-22. PubMed ID: 10092084
[TBL] [Abstract][Full Text] [Related]
8. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
[TBL] [Abstract][Full Text] [Related]
9. A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.
Johnson JB; Borisevich V; Rockx B; Parks GD
J Virol; 2015 Jan; 89(2):989-98. PubMed ID: 25355897
[TBL] [Abstract][Full Text] [Related]
10. A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System.
Nag J; Mukesh RK; Suma SM; Kunnakkadan U; Kumar NA; Johnson JB
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941783
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.
Biswas M; Johnson JB; Kumar SR; Parks GD; Elankumarana S
J Virol; 2012 Dec; 86(23):12708-16. PubMed ID: 22973037
[TBL] [Abstract][Full Text] [Related]
12. Function of small hydrophobic proteins of paramyxovirus.
Wilson RL; Fuentes SM; Wang P; Taddeo EC; Klatt A; Henderson AJ; He B
J Virol; 2006 Feb; 80(4):1700-9. PubMed ID: 16439527
[TBL] [Abstract][Full Text] [Related]
13. Ligation of human CD46 with purified complement C3b or F(ab')(2) of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages.
Hirano A; Kurita-Taniguchi M; Katayama Y; Matsumoto M; Wong TC; Seya T
J Biochem; 2002 Jul; 132(1):83-91. PubMed ID: 12097164
[TBL] [Abstract][Full Text] [Related]
14. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.
Isaacs SN; Argyropoulos E; Sfyroera G; Mohammad S; Lambris JD
J Virol; 2003 Aug; 77(15):8256-62. PubMed ID: 12857894
[TBL] [Abstract][Full Text] [Related]
15. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
[TBL] [Abstract][Full Text] [Related]
16. Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens.
Persson BD; Schmitz NB; Santiago C; Zocher G; Larvie M; Scheu U; Casasnovas JM; Stehle T
PLoS Pathog; 2010 Sep; 6(9):e1001122. PubMed ID: 20941397
[TBL] [Abstract][Full Text] [Related]
17. Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.
Mark L; Proctor DG; Blackbourn DJ; Blom AM; Spiller OB
Immunology; 2008 Feb; 123(2):228-38. PubMed ID: 17764451
[TBL] [Abstract][Full Text] [Related]
18. Functional Dissection of the Dominant Role of CD55 in Protecting Vesicular Stomatitis Virus against Complement-Mediated Neutralization.
Asok Kumar N; Muraleedharan Suma S; Kunnakkadan U; Nag J; Koolaparambil Mukesh R; Lyles DS; Johnson JB
Viruses; 2021 Feb; 13(3):. PubMed ID: 33652918
[TBL] [Abstract][Full Text] [Related]
19. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. I. Isolation and characterization of factor H: the serum cofactor for the C3b/C4b inactivator (factor I).
Kinoshita T; Nussenzweig V
J Immunol Methods; 1984 Jul; 71(2):247-57. PubMed ID: 6376638
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus regulates activation and processing of the third component of complement.
Mold C; Bradt BM; Nemerow GR; Cooper NR
J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
